A 10mg vial with 2.0mL of bacteriostatic water gives you 5mg/mL
(Baltim.) 100 , e26086 (2021)
Foundayo is approved for: Adults with a BMI of 30 or higher (obesity classification) Adults with a BMI of 27 or higher who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or abnormal cholesterol Foundayo is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, consistent with other GLP-1 receptor agonists
doi: 10.7326/0003-4819-143-8-200510180-00006 225 HenryRRBuseJBSestiGDaviesMJJensenKHBrettJet al
Patients interested in the Phase 3 programme should check ClinicalTrials.gov or the EU Clinical Trials Register for current trial identifiers, eligibility criteria, and participating sites, as the programme name and trial details should be verified against these authoritative registers
This means that 67 people with (severe) cardiovascular risk need to be on Wegovy consistently to avoid one cardiovascular event, for example, a heart attack